Employer Strategies On-Demand Webinars SmithRx Key Takeaways GLP-1s are highly effective for diabetes and obesity but surged demand and costs, use up ~587% and list prices near $1,000/mo, forcing prior auths and spiking employer drug spend
Response to Xing et al.: post-marketing safety concerns with Lecanemab: a pharmacovigilance study based on the FDA adverse event reporting system database
Pediatric Research 30, 396-403
UK Registered Pharmacy The MHRA regulates medicines and medical devices in the UK
Simrn, M., Vos, R., Janssens, J
The medication mimics the hormone GLP-1, which regulates appetite and food intake which can help lead to reduced hunger and subsequently, calorie consumption